microRNA information: hsa-miR-30b-3p
| Section | ID | link |
|---|---|---|
| Mature name: | hsa-miR-30b-3p | miRbase |
| Accession: | MIMAT0004589 | miRbase |
| Precursor name: | hsa-mir-30b | miRbase |
| Precursor accession: | MI0000441 | miRbase |
| Symbol: | MIR30B | HGNC |
| RefSeq ID: | NR_029666 | GenBank |
| Sequence: | CUGGGAGGUGGAUGUUUACUUC |
Reported expression in cancers: hsa-miR-30b-3p
| miRNA | cancer | regulation | reporting | PUBMED | method |
|---|---|---|---|---|---|
| hsa-miR-30b-3p | bladder cancer | downregulation | "In the first - discovery - phase microarray cards ......" | 27468885 | Microarray; qPCR |
| hsa-miR-30b-3p | breast cancer | deregulation | "Real-time reverse transcription-polymerase chain r ......" | 26034677 | Reverse transcription PCR; qPCR |
| hsa-miR-30b-3p | colorectal cancer | downregulation | "In this study we investigated the role of miR-30b ......" | 24293274 | |
| hsa-miR-30b-3p | colorectal cancer | downregulation | "In the present study we show that miR-30b is an im ......" | 24593661 | |
| hsa-miR-30b-3p | esophageal cancer | deregulation | "The expression profiles of miRNAs in paired EC and ......" | 23761828 | Microarray; qPCR |
| hsa-miR-30b-3p | gastric cancer | upregulation | "In the analysis by real-time PCR-based miRNA array ......" | 22407237 | qPCR; Microarray |
| hsa-miR-30b-3p | gastric cancer | downregulation | "However little is known about the potential role o ......" | 25170877 | |
| hsa-miR-30b-3p | gastric cancer | downregulation | "Flow cytometry was used to examine the effect of m ......" | 26309359 | |
| hsa-miR-30b-3p | gastric cancer | upregulation | "The present study was designed to investigate the ......" | 27729002 | |
| hsa-miR-30b-3p | liver cancer | upregulation | "Up-regulation of miR-15a miR-16 miR-27b miR-30b mi ......" | 24314246 | qPCR |
| hsa-miR-30b-3p | lung cancer | deregulation | "Therefore we conduct to systematically identify mi ......" | 26870998 | Microarray |
| hsa-miR-30b-3p | lung squamous cell cancer | deregulation | "Locked nucleic acids miRNA microarray expression p ......" | 20508945 | Microarray |
| hsa-miR-30b-3p | lung squamous cell cancer | downregulation | "Increasing evidences indicate that miR-30 expressi ......" | 25249344 | Reverse transcription PCR; qPCR |
| hsa-miR-30b-3p | lung squamous cell cancer | upregulation | "microRNA 30b inhibits cell invasion and migration ......" | 26388700 | |
| hsa-miR-30b-3p | lymphoma | deregulation | "We found miR-34a miR-146a and miR-193b to be up-re ......" | 25862860 |
Reported cancer pathway affected by hsa-miR-30b-3p
| miRNA | cancer | pathway | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-30b-3p | breast cancer | Apoptosis pathway | "Mir 30 reduction maintains self renewal and inhibi ......" | 20498642 | |
| hsa-miR-30b-3p | breast cancer | Apoptosis pathway | "Trastuzumab produces therapeutic actions by upregu ......" | 22384020 | Luciferase |
| hsa-miR-30b-3p | breast cancer | Apoptosis pathway | "MicroRNA miR 30 family regulates non attachment gr ......" | 23445407 | |
| hsa-miR-30b-3p | colorectal cancer | Apoptosis pathway | "MicroRNA 30b functions as a tumour suppressor in h ......" | 24293274 | |
| hsa-miR-30b-3p | colorectal cancer | Epithelial mesenchymal transition pathway | "miR 30b regulates migration and invasion of human ......" | 24593661 | |
| hsa-miR-30b-3p | gastric cancer | Apoptosis pathway | "miR 30b down regulated in gastric cancer promotes ......" | 25170877 | Flow cytometry; Western blot; Luciferase |
| hsa-miR-30b-3p | gastric cancer | Apoptosis pathway; Epithelial mesenchymal transition pathway | "MiR 30b suppresses tumor migration and invasion by ......" | 26309359 | Flow cytometry; Western blot; Luciferase |
| hsa-miR-30b-3p | gastric cancer | Apoptosis pathway | "miR 30 functions as an oncomiR in gastric cancer c ......" | 27729002 | |
| hsa-miR-30b-3p | thyroid cancer | Epithelial mesenchymal transition pathway | "We identified two significantly decreased microRNA ......" | 20498632 |
Reported cancer prognosis affected by hsa-miR-30b-3p
| miRNA | cancer | prognosis | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-30b-3p | breast cancer | metastasis; tumorigenesis | "Mir 30 reduction maintains self renewal and inhibi ......" | 20498642 | |
| hsa-miR-30b-3p | breast cancer | metastasis | "Real Time RT-PCR was performed to identify the miR ......" | 22524830 | |
| hsa-miR-30b-3p | colorectal cancer | staging; worse prognosis; differentiation; malignant trasformation | "MicroRNA 30b functions as a tumour suppressor in h ......" | 24293274 | |
| hsa-miR-30b-3p | colorectal cancer | metastasis; cell migration | "miR 30b regulates migration and invasion of human ......" | 24593661 | |
| hsa-miR-30b-3p | colorectal cancer | tumorigenesis; motility | "Here through bioinformatic analyses and functional ......" | 24909917 | |
| hsa-miR-30b-3p | colorectal cancer | malignant trasformation | "MiR-30c belongs to miR-30 family and is involved i ......" | 25799050 | |
| hsa-miR-30b-3p | gastric cancer | metastasis | "Decreased miR 30b 5p expression by DNMT1 methylati ......" | 24913034 | |
| hsa-miR-30b-3p | gastric cancer | tumorigenesis | "miR 30b down regulated in gastric cancer promotes ......" | 25170877 | Flow cytometry; Western blot; Luciferase |
| hsa-miR-30b-3p | gastric cancer | metastasis | "MiR 30b suppresses tumor migration and invasion by ......" | 26309359 | Flow cytometry; Western blot; Luciferase |
| hsa-miR-30b-3p | lung squamous cell cancer | drug resistance; tumorigenesis; progression; poor survival | "miR 30b and miR 30c expression predicted response ......" | 24286402 | |
| hsa-miR-30b-3p | lung squamous cell cancer | tumorigenesis | "Increasing evidences indicate that miR-30 expressi ......" | 25249344 | Luciferase; Western blot; MTT assay |
| hsa-miR-30b-3p | lung squamous cell cancer | metastasis | "microRNA 30b inhibits cell invasion and migration ......" | 26388700 | Western blot; Luciferase; Wound Healing Assay |
| hsa-miR-30b-3p | thyroid cancer | cell migration | "However specific miRNAs are downregulated in ATC s ......" | 25202329 |
Reported gene related to hsa-miR-30b-3p
| miRNA | cancer | gene | reporting | PUBMED |
|---|---|---|---|---|
| hsa-miR-30b-3p | breast cancer | ANXA5 | "An Annexin-V assay revealed that miR-26a but not m ......" | 22384020 |
| hsa-miR-30b-3p | prostate cancer | AR | "Results uncovered miR-30 family members as direct ......" | 27683042 |
| hsa-miR-30b-3p | thyroid cancer | ATM | "However specific miRNAs are downregulated in ATC s ......" | 25202329 |
| hsa-miR-30b-3p | gastric cancer | BECN1 | "Fluorouracil induces autophagy related gastric car ......" | 26209295 |
| hsa-miR-30b-3p | breast cancer | CCNE2 | "A luciferase-based reporter assay demonstrated tha ......" | 22384020 |
| hsa-miR-30b-3p | thyroid cancer | CHST14 | "We identified two significantly decreased microRNA ......" | 20498632 |
| hsa-miR-30b-3p | lung squamous cell cancer | CTHRC1 | "MiR-30b was down-regulated and Cthrc1 up-regulated ......" | 26388700 |
| hsa-miR-30b-3p | gastric cancer | DNMT1 | "Decreased miR 30b 5p expression by DNMT1 methylati ......" | 24913034 |
| hsa-miR-30b-3p | gastric cancer | EIF5A2 | "MiR 30b suppresses tumor migration and invasion by ......" | 26309359 |
| hsa-miR-30b-3p | breast cancer | ITGA9 | "Furthermore bioinformatics analysis revealed the p ......" | 26781040 |
| hsa-miR-30b-3p | breast cancer | ITGB3 | "Enforced constitutive expression of mir-30 in BT-I ......" | 20498642 |
| hsa-miR-30b-3p | gastric cancer | NOL3 | "We examined the effect of miR-30b mimics on the ap ......" | 25170877 |
| hsa-miR-30b-3p | pancreatic cancer | PROM1 | "Using miRNA microarray we found that the expressio ......" | 26965588 |
| hsa-miR-30b-3p | lung squamous cell cancer | RAB18 | "Both miR-30b and miR-30c miR-30b/c were found havi ......" | 25249344 |
| hsa-miR-30b-3p | gastric cancer | SERPINE1 | "miR-30b may function as a novel tumor suppressor g ......" | 25170877 |
| hsa-miR-30b-3p | colorectal cancer | SIX1 | "miR 30b regulates migration and invasion of human ......" | 24593661 |
| hsa-miR-30b-3p | gastric cancer | TP53 | "miR 30 functions as an oncomiR in gastric cancer c ......" | 27729002 |
| hsa-miR-30b-3p | lung squamous cell cancer | TXK | "miR 30b and miR 30c expression predicted response ......" | 24286402 |
| hsa-miR-30b-3p | breast cancer | UBE2I | "Enforced constitutive expression of mir-30 in BT-I ......" | 20498642 |
Expression profile in cancer corhorts:
Putative target regulations
| miRNA | Gene | Cancer | Interaction | Correlation beta |
|---|---|---|---|---|
hsa-miR-30b-3p | TNFSF9 | 10 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; PAAD; THCA | MirTarget | TCGA BLCA -0.417; TCGA BRCA -0.137; TCGA ESCA -0.324; TCGA HNSC -0.193; TCGA KIRC -0.993; TCGA KIRP -0.349; TCGA LIHC -0.228; TCGA LUAD -0.172; TCGA PAAD -0.402; TCGA THCA -0.702 |
hsa-miR-30b-3p | LIX1L | 11 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.328; TCGA BRCA -0.068; TCGA COAD -0.21; TCGA ESCA -0.305; TCGA KIRC -0.264; TCGA KIRP -0.101; TCGA PAAD -0.108; TCGA PRAD -0.16; TCGA THCA -0.126; TCGA STAD -0.462; TCGA UCEC -0.248 |
hsa-miR-30b-3p | JAK3 | 11 cancers: BLCA; BRCA; CESC; KIRC; KIRP; LIHC; LUAD; LUSC; PRAD; THCA; STAD | MirTarget | TCGA BLCA -0.34; TCGA BRCA -0.214; TCGA CESC -0.143; TCGA KIRC -0.801; TCGA KIRP -0.431; TCGA LIHC -0.299; TCGA LUAD -0.139; TCGA LUSC -0.233; TCGA PRAD -0.264; TCGA THCA -0.552; TCGA STAD -0.248 |
hsa-miR-30b-3p | CD84 | 11 cancers: BLCA; CESC; COAD; ESCA; KIRC; LIHC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.701; TCGA CESC -0.257; TCGA COAD -0.481; TCGA ESCA -0.397; TCGA KIRC -0.744; TCGA LIHC -0.265; TCGA PAAD -0.31; TCGA PRAD -0.338; TCGA THCA -0.375; TCGA STAD -0.239; TCGA UCEC -0.142 |
hsa-miR-30b-3p | PDPN | 15 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.647; TCGA BRCA -0.181; TCGA COAD -0.463; TCGA ESCA -0.66; TCGA HNSC -0.494; TCGA LGG -0.268; TCGA LIHC -0.561; TCGA LUAD -0.158; TCGA LUSC -0.159; TCGA OV -0.21; TCGA PAAD -0.588; TCGA PRAD -0.519; TCGA THCA -0.641; TCGA STAD -0.136; TCGA UCEC -0.284 |
hsa-miR-30b-3p | NID1 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LGG; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.326; TCGA BRCA -0.07; TCGA COAD -0.213; TCGA ESCA -0.225; TCGA HNSC -0.406; TCGA KIRC -0.377; TCGA LGG -0.159; TCGA PAAD -0.257; TCGA PRAD -0.389; TCGA SARC -0.185; TCGA THCA -0.111; TCGA STAD -0.179; TCGA UCEC -0.184 |
hsa-miR-30b-3p | ADAM19 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.736; TCGA BRCA -0.176; TCGA CESC -0.277; TCGA COAD -0.251; TCGA ESCA -0.357; TCGA HNSC -0.207; TCGA KIRC -0.52; TCGA KIRP -0.306; TCGA LUAD -0.197; TCGA LUSC -0.364; TCGA PAAD -0.258; TCGA PRAD -0.414; TCGA SARC -0.321; TCGA THCA -0.528; TCGA STAD -0.243; TCGA UCEC -0.16 |
hsa-miR-30b-3p | PNMA2 | 9 cancers: BLCA; BRCA; COAD; KIRC; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.453; TCGA BRCA -0.169; TCGA COAD -0.347; TCGA KIRC -0.78; TCGA PRAD -0.358; TCGA SARC -0.422; TCGA THCA -0.494; TCGA STAD -0.288; TCGA UCEC -0.297 |
hsa-miR-30b-3p | KLHL20 | 11 cancers: BLCA; COAD; ESCA; KIRC; LGG; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.059; TCGA COAD -0.077; TCGA ESCA -0.089; TCGA KIRC -0.077; TCGA LGG -0.054; TCGA OV -0.063; TCGA PAAD -0.117; TCGA PRAD -0.131; TCGA SARC -0.11; TCGA STAD -0.095; TCGA UCEC -0.133 |
hsa-miR-30b-3p | FCGR2C | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LIHC; LUSC; PAAD; PRAD; THCA; STAD | MirTarget | TCGA BLCA -0.638; TCGA BRCA -0.069; TCGA CESC -0.264; TCGA COAD -0.604; TCGA ESCA -0.492; TCGA KIRC -0.682; TCGA KIRP -0.226; TCGA LGG -0.247; TCGA LIHC -0.254; TCGA LUSC -0.171; TCGA PAAD -0.336; TCGA PRAD -0.234; TCGA THCA -0.434; TCGA STAD -0.482 |
hsa-miR-30b-3p | CSDC2 | 9 cancers: BLCA; BRCA; COAD; ESCA; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.951; TCGA BRCA -0.409; TCGA COAD -0.737; TCGA ESCA -0.394; TCGA PRAD -0.442; TCGA SARC -0.505; TCGA THCA -0.538; TCGA STAD -0.536; TCGA UCEC -0.66 |
hsa-miR-30b-3p | HEYL | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; PRAD; THCA; STAD; UCEC | MirTarget; mirMAP | TCGA BLCA -0.217; TCGA BRCA -0.193; TCGA COAD -0.295; TCGA ESCA -0.207; TCGA HNSC -0.212; TCGA KIRC -0.472; TCGA PRAD -0.103; TCGA THCA -0.187; TCGA STAD -0.297; TCGA UCEC -0.28 |
hsa-miR-30b-3p | CPNE5 | 10 cancers: BLCA; BRCA; CESC; KIRC; LIHC; LUSC; PAAD; PRAD; THCA; UCEC | MirTarget | TCGA BLCA -0.345; TCGA BRCA -0.202; TCGA CESC -0.161; TCGA KIRC -0.453; TCGA LIHC -0.325; TCGA LUSC -0.284; TCGA PAAD -0.193; TCGA PRAD -0.411; TCGA THCA -0.455; TCGA UCEC -0.316 |
hsa-miR-30b-3p | MALL | 10 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LIHC; PAAD; PRAD; THCA | MirTarget | TCGA BLCA -0.319; TCGA BRCA -0.086; TCGA CESC -0.233; TCGA HNSC -0.19; TCGA KIRC -0.47; TCGA KIRP -0.195; TCGA LIHC -0.184; TCGA PAAD -0.293; TCGA PRAD -0.144; TCGA THCA -0.23 |
hsa-miR-30b-3p | SAMD4A | 9 cancers: BLCA; COAD; ESCA; KIRC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.377; TCGA COAD -0.262; TCGA ESCA -0.181; TCGA KIRC -0.134; TCGA PAAD -0.14; TCGA PRAD -0.31; TCGA SARC -0.204; TCGA STAD -0.346; TCGA UCEC -0.405 |
hsa-miR-30b-3p | HSPB7 | 9 cancers: BLCA; COAD; ESCA; LIHC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.985; TCGA COAD -0.866; TCGA ESCA -0.7; TCGA LIHC -0.224; TCGA PAAD -0.358; TCGA PRAD -0.599; TCGA SARC -0.655; TCGA STAD -1.114; TCGA UCEC -0.751 |
hsa-miR-30b-3p | KIAA1755 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.993; TCGA BRCA -0.095; TCGA CESC -0.211; TCGA COAD -0.269; TCGA ESCA -0.497; TCGA HNSC -0.182; TCGA LUAD -0.144; TCGA LUSC -0.281; TCGA PAAD -0.395; TCGA PRAD -0.395; TCGA SARC -0.414; TCGA THCA -0.602; TCGA STAD -0.338; TCGA UCEC -0.4 |
hsa-miR-30b-3p | FAM114A1 | 11 cancers: BLCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.109; TCGA HNSC -0.141; TCGA KIRC -0.067; TCGA KIRP -0.14; TCGA LUAD -0.1; TCGA LUSC -0.075; TCGA PAAD -0.168; TCGA PRAD -0.152; TCGA SARC -0.209; TCGA THCA -0.12; TCGA STAD -0.092 |
hsa-miR-30b-3p | SCG2 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.385; TCGA BRCA -0.214; TCGA COAD -0.566; TCGA ESCA -0.415; TCGA HNSC -0.198; TCGA KIRC -0.833; TCGA KIRP -0.293; TCGA LIHC -0.454; TCGA PRAD -0.248; TCGA THCA -0.54; TCGA STAD -0.55; TCGA UCEC -0.447 |
hsa-miR-30b-3p | SV2B | 10 cancers: BLCA; CESC; COAD; ESCA; LIHC; OV; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.632; TCGA CESC -0.427; TCGA COAD -0.736; TCGA ESCA -0.546; TCGA LIHC -0.41; TCGA OV -0.267; TCGA PRAD -0.483; TCGA THCA -0.439; TCGA STAD -0.601; TCGA UCEC -0.525 |
hsa-miR-30b-3p | BMP8A | 11 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; UCEC | MirTarget | TCGA BLCA -0.182; TCGA COAD -0.193; TCGA ESCA -0.175; TCGA HNSC -0.21; TCGA KIRC -0.386; TCGA KIRP -0.1; TCGA LIHC -0.251; TCGA LUAD -0.21; TCGA LUSC -0.355; TCGA PAAD -0.249; TCGA UCEC -0.162 |
hsa-miR-30b-3p | PAPPA | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LIHC; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.437; TCGA BRCA -0.153; TCGA COAD -0.437; TCGA ESCA -0.437; TCGA HNSC -0.373; TCGA LIHC -0.268; TCGA LUSC -0.164; TCGA PAAD -0.305; TCGA PRAD -0.461; TCGA STAD -0.145; TCGA UCEC -0.572 |
hsa-miR-30b-3p | PIK3CD | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LIHC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.531; TCGA BRCA -0.127; TCGA COAD -0.195; TCGA ESCA -0.431; TCGA HNSC -0.213; TCGA KIRC -0.256; TCGA LIHC -0.241; TCGA PAAD -0.169; TCGA PRAD -0.333; TCGA THCA -0.414; TCGA STAD -0.211; TCGA UCEC -0.103 |
hsa-miR-30b-3p | FBXL7 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LIHC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.414; TCGA BRCA -0.098; TCGA CESC -0.179; TCGA COAD -0.399; TCGA ESCA -0.272; TCGA KIRC -0.19; TCGA KIRP -0.199; TCGA LGG -0.1; TCGA LIHC -0.156; TCGA PAAD -0.256; TCGA PRAD -0.226; TCGA SARC -0.129; TCGA THCA -0.195; TCGA STAD -0.459; TCGA UCEC -0.293 |
hsa-miR-30b-3p | TES | 12 cancers: BLCA; HNSC; KIRC; KIRP; LGG; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.104; TCGA HNSC -0.196; TCGA KIRC -0.156; TCGA KIRP -0.248; TCGA LGG -0.112; TCGA LUAD -0.084; TCGA PAAD -0.205; TCGA PRAD -0.206; TCGA SARC -0.386; TCGA THCA -0.074; TCGA STAD -0.086; TCGA UCEC -0.134 |
hsa-miR-30b-3p | PCDHB16 | 10 cancers: BLCA; BRCA; HNSC; KIRC; LGG; LIHC; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.207; TCGA BRCA -0.086; TCGA HNSC -0.244; TCGA KIRC -0.185; TCGA LGG -0.221; TCGA LIHC -0.265; TCGA PAAD -0.152; TCGA THCA -0.291; TCGA STAD -0.321; TCGA UCEC -0.161 |
hsa-miR-30b-3p | CDC42EP1 | 11 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LGG; PAAD; PRAD; THCA; UCEC | MirTarget | TCGA BLCA -0.303; TCGA BRCA -0.106; TCGA CESC -0.139; TCGA HNSC -0.088; TCGA KIRC -0.185; TCGA KIRP -0.115; TCGA LGG -0.106; TCGA PAAD -0.167; TCGA PRAD -0.063; TCGA THCA -0.154; TCGA UCEC -0.127 |
hsa-miR-30b-3p | DLG4 | 11 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LIHC; OV; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.103; TCGA BRCA -0.072; TCGA COAD -0.303; TCGA ESCA -0.14; TCGA KIRC -0.153; TCGA KIRP -0.162; TCGA LIHC -0.112; TCGA OV -0.153; TCGA PRAD -0.316; TCGA STAD -0.125; TCGA UCEC -0.12 |
hsa-miR-30b-3p | GAL3ST4 | 16 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.281; TCGA BRCA -0.141; TCGA COAD -0.164; TCGA ESCA -0.341; TCGA KIRC -0.77; TCGA KIRP -0.227; TCGA LGG -0.152; TCGA LIHC -0.332; TCGA LUAD -0.124; TCGA LUSC -0.097; TCGA PAAD -0.254; TCGA PRAD -0.244; TCGA SARC -0.112; TCGA THCA -0.379; TCGA STAD -0.152; TCGA UCEC -0.171 |
hsa-miR-30b-3p | RASGRP4 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; PAAD; PRAD; THCA; UCEC | MirTarget | TCGA BLCA -0.651; TCGA BRCA -0.179; TCGA CESC -0.144; TCGA COAD -0.418; TCGA ESCA -0.242; TCGA KIRC -0.561; TCGA KIRP -0.163; TCGA LGG -0.138; TCGA PAAD -0.189; TCGA PRAD -0.295; TCGA THCA -0.311; TCGA UCEC -0.164 |
hsa-miR-30b-3p | KCTD10 | 10 cancers: BLCA; COAD; ESCA; HNSC; LIHC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.112; TCGA COAD -0.071; TCGA ESCA -0.092; TCGA HNSC -0.121; TCGA LIHC -0.052; TCGA PAAD -0.115; TCGA PRAD -0.137; TCGA SARC -0.113; TCGA STAD -0.201; TCGA UCEC -0.129 |
hsa-miR-30b-3p | ZCCHC24 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.461; TCGA BRCA -0.189; TCGA COAD -0.332; TCGA ESCA -0.37; TCGA HNSC -0.151; TCGA PAAD -0.362; TCGA PRAD -0.197; TCGA THCA -0.15; TCGA STAD -0.496; TCGA UCEC -0.382 |
hsa-miR-30b-3p | GM2A | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.138; TCGA CESC -0.155; TCGA COAD -0.102; TCGA ESCA -0.355; TCGA HNSC -0.198; TCGA KIRC -0.286; TCGA LIHC -0.085; TCGA PRAD -0.069; TCGA THCA -0.069; TCGA STAD -0.111; TCGA UCEC -0.077 |
hsa-miR-30b-3p | PMP22 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.403; TCGA BRCA -0.061; TCGA COAD -0.335; TCGA ESCA -0.253; TCGA HNSC -0.196; TCGA KIRC -0.354; TCGA KIRP -0.127; TCGA LIHC -0.142; TCGA PAAD -0.339; TCGA PRAD -0.419; TCGA SARC -0.201; TCGA THCA -0.156; TCGA STAD -0.276; TCGA UCEC -0.439 |
hsa-miR-30b-3p | TSPAN18 | 9 cancers: BLCA; BRCA; COAD; KIRC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.385; TCGA BRCA -0.082; TCGA COAD -0.294; TCGA KIRC -0.357; TCGA PAAD -0.325; TCGA PRAD -0.527; TCGA SARC -0.225; TCGA STAD -0.261; TCGA UCEC -0.505 |
hsa-miR-30b-3p | IGFBP5 | 11 cancers: BLCA; COAD; ESCA; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.484; TCGA COAD -0.468; TCGA ESCA -0.323; TCGA LUSC -0.161; TCGA OV -0.188; TCGA PAAD -0.326; TCGA PRAD -0.306; TCGA SARC -0.23; TCGA THCA -0.202; TCGA STAD -0.402; TCGA UCEC -0.396 |
hsa-miR-30b-3p | RGS4 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.694; TCGA BRCA -0.134; TCGA COAD -0.669; TCGA ESCA -0.644; TCGA HNSC -0.395; TCGA KIRC -0.188; TCGA KIRP -0.347; TCGA LUAD -0.242; TCGA LUSC -0.26; TCGA PRAD -0.23; TCGA THCA -0.549; TCGA STAD -0.658; TCGA UCEC -0.417 |
hsa-miR-30b-3p | ARNTL2 | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA | MirTarget | TCGA BLCA -0.347; TCGA CESC -0.177; TCGA COAD -0.172; TCGA ESCA -0.229; TCGA HNSC -0.235; TCGA KIRC -0.427; TCGA KIRP -0.415; TCGA LIHC -0.349; TCGA LUAD -0.579; TCGA LUSC -0.384; TCGA OV -0.258; TCGA PRAD -0.335; TCGA SARC -0.252; TCGA THCA -0.414 |
hsa-miR-30b-3p | RELT | 10 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; THCA | MirTarget | TCGA BLCA -0.161; TCGA BRCA -0.19; TCGA ESCA -0.188; TCGA HNSC -0.126; TCGA KIRC -0.654; TCGA KIRP -0.197; TCGA LIHC -0.286; TCGA LUAD -0.132; TCGA LUSC -0.084; TCGA THCA -0.265 |
hsa-miR-30b-3p | MAP1B | 9 cancers: BLCA; COAD; HNSC; KIRC; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.474; TCGA COAD -0.372; TCGA HNSC -0.147; TCGA KIRC -0.198; TCGA PRAD -0.443; TCGA SARC -0.296; TCGA THCA -0.137; TCGA STAD -0.592; TCGA UCEC -0.176 |
hsa-miR-30b-3p | CADM3 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LIHC; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -1.056; TCGA BRCA -0.31; TCGA CESC -0.292; TCGA COAD -0.877; TCGA ESCA -0.795; TCGA KIRC -0.741; TCGA KIRP -0.591; TCGA LIHC -0.357; TCGA PRAD -0.516; TCGA SARC -0.835; TCGA THCA -1.08; TCGA STAD -0.875; TCGA UCEC -0.446 |
hsa-miR-30b-3p | ARHGAP1 | 9 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; PRAD; SARC; THCA; STAD | MirTarget; mirMAP | TCGA BLCA -0.192; TCGA BRCA -0.074; TCGA ESCA -0.084; TCGA HNSC -0.147; TCGA KIRC -0.115; TCGA PRAD -0.091; TCGA SARC -0.242; TCGA THCA -0.074; TCGA STAD -0.115 |
hsa-miR-30b-3p | CCL22 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LIHC; LUSC; PAAD; PRAD; THCA; UCEC | MirTarget | TCGA BLCA -0.305; TCGA BRCA -0.257; TCGA CESC -0.38; TCGA COAD -0.23; TCGA ESCA -0.276; TCGA KIRC -0.484; TCGA KIRP -0.172; TCGA LIHC -0.303; TCGA LUSC -0.229; TCGA PAAD -0.427; TCGA PRAD -0.262; TCGA THCA -0.759; TCGA UCEC -0.204 |
hsa-miR-30b-3p | F2RL2 | 11 cancers: BLCA; BRCA; HNSC; KIRC; LGG; LUSC; OV; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.401; TCGA BRCA -0.316; TCGA HNSC -0.279; TCGA KIRC -0.156; TCGA LGG -0.261; TCGA LUSC -0.39; TCGA OV -0.269; TCGA PAAD -0.258; TCGA THCA -0.568; TCGA STAD -0.287; TCGA UCEC -0.326 |
hsa-miR-30b-3p | RIMS3 | 10 cancers: BLCA; CESC; ESCA; HNSC; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.197; TCGA CESC -0.263; TCGA ESCA -0.366; TCGA HNSC -0.386; TCGA OV -0.24; TCGA PRAD -0.364; TCGA SARC -0.611; TCGA THCA -0.143; TCGA STAD -0.242; TCGA UCEC -0.265 |
hsa-miR-30b-3p | MPP2 | 9 cancers: BLCA; COAD; LIHC; LUAD; OV; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.167; TCGA COAD -0.391; TCGA LIHC -0.39; TCGA LUAD -0.143; TCGA OV -0.221; TCGA PRAD -0.56; TCGA SARC -0.412; TCGA STAD -0.35; TCGA UCEC -0.252 |
hsa-miR-30b-3p | ATP2B4 | 12 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.297; TCGA COAD -0.25; TCGA ESCA -0.224; TCGA HNSC -0.08; TCGA KIRC -0.176; TCGA KIRP -0.134; TCGA PAAD -0.117; TCGA PRAD -0.527; TCGA SARC -0.281; TCGA THCA -0.097; TCGA STAD -0.421; TCGA UCEC -0.15 |
hsa-miR-30b-3p | NTM | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.493; TCGA BRCA -0.103; TCGA COAD -0.69; TCGA ESCA -0.606; TCGA HNSC -0.315; TCGA KIRC -0.482; TCGA KIRP -0.59; TCGA LIHC -0.456; TCGA LUAD -0.116; TCGA PAAD -0.505; TCGA THCA -0.626; TCGA STAD -0.379; TCGA UCEC -0.158 |
hsa-miR-30b-3p | CDKN1A | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LUAD; PAAD; PRAD; SARC | MirTarget | TCGA BLCA -0.188; TCGA BRCA -0.074; TCGA CESC -0.165; TCGA ESCA -0.232; TCGA HNSC -0.214; TCGA KIRC -0.263; TCGA LUAD -0.09; TCGA PAAD -0.128; TCGA PRAD -0.182; TCGA SARC -0.126 |
hsa-miR-30b-3p | GPC6 | 12 cancers: BLCA; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.914; TCGA COAD -0.563; TCGA ESCA -0.569; TCGA HNSC -0.397; TCGA KIRC -0.216; TCGA LGG -0.152; TCGA LUAD -0.399; TCGA LUSC -0.323; TCGA PRAD -0.204; TCGA THCA -0.487; TCGA STAD -0.352; TCGA UCEC -0.222 |
hsa-miR-30b-3p | SPI1 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LGG; LIHC; PAAD; PRAD; THCA | MirTarget | TCGA BLCA -0.662; TCGA BRCA -0.228; TCGA CESC -0.246; TCGA COAD -0.352; TCGA ESCA -0.385; TCGA KIRC -0.674; TCGA LGG -0.176; TCGA LIHC -0.171; TCGA PAAD -0.232; TCGA PRAD -0.161; TCGA THCA -0.417 |
hsa-miR-30b-3p | CSF3R | 11 cancers: BLCA; BRCA; CESC; COAD; KIRC; KIRP; LGG; LIHC; PAAD; PRAD; THCA | MirTarget | TCGA BLCA -0.338; TCGA BRCA -0.136; TCGA CESC -0.249; TCGA COAD -0.531; TCGA KIRC -0.848; TCGA KIRP -0.274; TCGA LGG -0.145; TCGA LIHC -0.206; TCGA PAAD -0.278; TCGA PRAD -0.23; TCGA THCA -0.326 |
hsa-miR-30b-3p | NCKAP1L | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LIHC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.821; TCGA BRCA -0.119; TCGA CESC -0.245; TCGA COAD -0.382; TCGA ESCA -0.321; TCGA KIRC -0.734; TCGA KIRP -0.175; TCGA LGG -0.168; TCGA LIHC -0.23; TCGA PAAD -0.287; TCGA PRAD -0.345; TCGA SARC -0.238; TCGA THCA -0.435; TCGA STAD -0.223; TCGA UCEC -0.164 |
hsa-miR-30b-3p | CSMD2 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC | MirTarget | TCGA BLCA -0.419; TCGA BRCA -0.159; TCGA CESC -0.222; TCGA COAD -0.321; TCGA ESCA -0.467; TCGA HNSC -0.498; TCGA KIRC -0.271; TCGA LIHC -0.274; TCGA LUAD -0.365; TCGA LUSC -0.337 |
hsa-miR-30b-3p | ST8SIA4 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LIHC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.249; TCGA BRCA -0.061; TCGA CESC -0.16; TCGA COAD -0.309; TCGA ESCA -0.217; TCGA KIRC -0.971; TCGA KIRP -0.358; TCGA LGG -0.104; TCGA LIHC -0.201; TCGA PAAD -0.218; TCGA PRAD -0.28; TCGA THCA -0.166; TCGA STAD -0.204; TCGA UCEC -0.236 |
hsa-miR-30b-3p | KATNAL1 | 9 cancers: BLCA; COAD; ESCA; HNSC; KIRC; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.474; TCGA COAD -0.187; TCGA ESCA -0.312; TCGA HNSC -0.085; TCGA KIRC -0.129; TCGA PRAD -0.289; TCGA THCA -0.081; TCGA STAD -0.452; TCGA UCEC -0.239 |
hsa-miR-30b-3p | CSF2RB | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LIHC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.473; TCGA BRCA -0.171; TCGA CESC -0.279; TCGA COAD -0.433; TCGA ESCA -0.246; TCGA KIRC -0.46; TCGA KIRP -0.199; TCGA LGG -0.13; TCGA LIHC -0.201; TCGA PAAD -0.32; TCGA PRAD -0.327; TCGA THCA -0.526; TCGA STAD -0.155; TCGA UCEC -0.336 |
hsa-miR-30b-3p | PLEKHG2 | 12 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LGG; LIHC; PAAD; PRAD; THCA; STAD | MirTarget | TCGA BLCA -0.182; TCGA BRCA -0.061; TCGA COAD -0.141; TCGA HNSC -0.067; TCGA KIRC -0.522; TCGA KIRP -0.249; TCGA LGG -0.119; TCGA LIHC -0.122; TCGA PAAD -0.127; TCGA PRAD -0.164; TCGA THCA -0.328; TCGA STAD -0.125 |
hsa-miR-30b-3p | MSN | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.541; TCGA CESC -0.162; TCGA COAD -0.31; TCGA ESCA -0.512; TCGA HNSC -0.249; TCGA KIRC -0.087; TCGA PAAD -0.266; TCGA PRAD -0.355; TCGA SARC -0.145; TCGA STAD -0.217; TCGA UCEC -0.097 |
hsa-miR-30b-3p | PARVG | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LIHC; PAAD; PRAD; THCA | MirTarget | TCGA BLCA -0.591; TCGA BRCA -0.219; TCGA CESC -0.194; TCGA COAD -0.271; TCGA ESCA -0.307; TCGA KIRC -0.939; TCGA KIRP -0.23; TCGA LGG -0.184; TCGA LIHC -0.223; TCGA PAAD -0.196; TCGA PRAD -0.143; TCGA THCA -0.455 |
hsa-miR-30b-3p | PRND | 9 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LIHC; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.499; TCGA BRCA -0.164; TCGA COAD -0.629; TCGA ESCA -0.328; TCGA KIRC -0.668; TCGA LIHC -0.287; TCGA PAAD -0.357; TCGA STAD -0.585; TCGA UCEC -0.379 |
hsa-miR-30b-3p | BCL9L | 9 cancers: BLCA; CESC; HNSC; KIRC; KIRP; LIHC; PAAD; SARC; THCA | MirTarget | TCGA BLCA -0.106; TCGA CESC -0.115; TCGA HNSC -0.163; TCGA KIRC -0.291; TCGA KIRP -0.147; TCGA LIHC -0.1; TCGA PAAD -0.116; TCGA SARC -0.108; TCGA THCA -0.106 |
hsa-miR-30b-3p | S1PR2 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LIHC; PAAD; PRAD; THCA; STAD | MirTarget | TCGA BLCA -0.184; TCGA BRCA -0.06; TCGA COAD -0.135; TCGA ESCA -0.23; TCGA HNSC -0.062; TCGA KIRP -0.219; TCGA LIHC -0.211; TCGA PAAD -0.108; TCGA PRAD -0.138; TCGA THCA -0.209; TCGA STAD -0.192 |
hsa-miR-30b-3p | FKBP7 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.169; TCGA BRCA -0.084; TCGA COAD -0.207; TCGA ESCA -0.217; TCGA HNSC -0.149; TCGA KIRC -0.176; TCGA KIRP -0.185; TCGA LGG -0.072; TCGA OV -0.18; TCGA PAAD -0.287; TCGA PRAD -0.216; TCGA THCA -0.132; TCGA STAD -0.272; TCGA UCEC -0.256 |
hsa-miR-30b-3p | PXDN | 12 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; THCA; UCEC | MirTarget | TCGA BLCA -0.541; TCGA BRCA -0.146; TCGA COAD -0.386; TCGA HNSC -0.353; TCGA KIRC -0.46; TCGA KIRP -0.212; TCGA LGG -0.126; TCGA LUAD -0.119; TCGA LUSC -0.233; TCGA PAAD -0.332; TCGA THCA -0.116; TCGA UCEC -0.167 |
hsa-miR-30b-3p | APOC2 | 9 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LGG; PAAD; THCA | MirTarget | TCGA BLCA -0.393; TCGA BRCA -0.196; TCGA CESC -0.27; TCGA COAD -0.518; TCGA HNSC -0.174; TCGA KIRC -0.639; TCGA LGG -0.22; TCGA PAAD -0.34; TCGA THCA -0.39 |
hsa-miR-30b-3p | NLRC3 | 9 cancers: BLCA; BRCA; ESCA; KIRC; KIRP; LIHC; PRAD; THCA; STAD | MirTarget | TCGA BLCA -0.361; TCGA BRCA -0.062; TCGA ESCA -0.165; TCGA KIRC -0.383; TCGA KIRP -0.152; TCGA LIHC -0.163; TCGA PRAD -0.131; TCGA THCA -0.227; TCGA STAD -0.264 |
hsa-miR-30b-3p | FCGR2A | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.713; TCGA BRCA -0.073; TCGA CESC -0.184; TCGA COAD -0.473; TCGA ESCA -0.416; TCGA HNSC -0.2; TCGA KIRC -0.603; TCGA KIRP -0.167; TCGA LGG -0.216; TCGA LIHC -0.272; TCGA PAAD -0.289; TCGA PRAD -0.151; TCGA THCA -0.315; TCGA STAD -0.149; TCGA UCEC -0.179 |
hsa-miR-30b-3p | RALB | 10 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LIHC; LUAD; PAAD; PRAD; UCEC | MirTarget | TCGA BLCA -0.136; TCGA BRCA -0.089; TCGA COAD -0.066; TCGA HNSC -0.15; TCGA KIRC -0.082; TCGA LIHC -0.059; TCGA LUAD -0.081; TCGA PAAD -0.167; TCGA PRAD -0.093; TCGA UCEC -0.109 |
hsa-miR-30b-3p | SIRPG | 12 cancers: BLCA; BRCA; ESCA; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | MirTarget | TCGA BLCA -0.478; TCGA BRCA -0.232; TCGA ESCA -0.245; TCGA KIRC -1.011; TCGA KIRP -0.381; TCGA LIHC -0.405; TCGA LUAD -0.149; TCGA LUSC -0.348; TCGA PAAD -0.364; TCGA PRAD -0.32; TCGA THCA -0.802; TCGA UCEC -0.198 |
hsa-miR-30b-3p | ATP6V0D2 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LIHC; PAAD; PRAD; THCA | MirTarget | TCGA BLCA -0.35; TCGA BRCA -0.133; TCGA COAD -0.4; TCGA ESCA -0.473; TCGA HNSC -0.236; TCGA LIHC -0.436; TCGA PAAD -0.367; TCGA PRAD -0.575; TCGA THCA -0.273 |
hsa-miR-30b-3p | CORO1A | 11 cancers: BLCA; BRCA; CESC; ESCA; KIRC; KIRP; LIHC; LUSC; PRAD; THCA; UCEC | MirTarget | TCGA BLCA -0.383; TCGA BRCA -0.288; TCGA CESC -0.188; TCGA ESCA -0.248; TCGA KIRC -0.764; TCGA KIRP -0.193; TCGA LIHC -0.252; TCGA LUSC -0.13; TCGA PRAD -0.251; TCGA THCA -0.503; TCGA UCEC -0.129 |
hsa-miR-30b-3p | CHST6 | 10 cancers: BLCA; BRCA; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.279; TCGA BRCA -0.158; TCGA KIRP -0.272; TCGA LUAD -0.232; TCGA LUSC -0.272; TCGA PAAD -0.362; TCGA PRAD -0.457; TCGA SARC -0.683; TCGA THCA -0.225; TCGA STAD -0.218 |
hsa-miR-30b-3p | CTSB | 10 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD | MirTarget | TCGA BLCA -0.389; TCGA BRCA -0.109; TCGA CESC -0.133; TCGA COAD -0.221; TCGA HNSC -0.157; TCGA KIRC -0.078; TCGA LUAD -0.156; TCGA LUSC -0.172; TCGA PAAD -0.203; TCGA PRAD -0.267 |
hsa-miR-30b-3p | CREB5 | 10 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.481; TCGA COAD -0.233; TCGA ESCA -0.34; TCGA HNSC -0.199; TCGA KIRC -0.428; TCGA KIRP -0.257; TCGA PRAD -0.131; TCGA THCA -0.294; TCGA STAD -0.265; TCGA UCEC -0.149 |
hsa-miR-30b-3p | CXCR5 | 14 cancers: BLCA; BRCA; CESC; ESCA; KIRC; KIRP; LIHC; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.552; TCGA BRCA -0.317; TCGA CESC -0.325; TCGA ESCA -0.29; TCGA KIRC -0.519; TCGA KIRP -0.2; TCGA LIHC -0.328; TCGA LUSC -0.218; TCGA PAAD -0.451; TCGA PRAD -0.349; TCGA SARC -0.441; TCGA THCA -0.948; TCGA STAD -0.216; TCGA UCEC -0.19 |
hsa-miR-30b-3p | ARSB | 11 cancers: BLCA; COAD; ESCA; KIRC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.238; TCGA COAD -0.143; TCGA ESCA -0.147; TCGA KIRC -0.087; TCGA OV -0.128; TCGA PAAD -0.111; TCGA PRAD -0.179; TCGA SARC -0.141; TCGA THCA -0.104; TCGA STAD -0.264; TCGA UCEC -0.079 |
hsa-miR-30b-3p | A1BG | 10 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LUAD; PRAD; THCA; STAD | MirTarget | TCGA BLCA -0.224; TCGA BRCA -0.244; TCGA COAD -0.248; TCGA ESCA -0.331; TCGA KIRC -0.283; TCGA KIRP -0.259; TCGA LUAD -0.148; TCGA PRAD -0.219; TCGA THCA -0.131; TCGA STAD -0.129 |
hsa-miR-30b-3p | FAM126A | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; OV; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.305; TCGA CESC -0.221; TCGA COAD -0.252; TCGA ESCA -0.419; TCGA HNSC -0.184; TCGA KIRC -0.091; TCGA KIRP -0.138; TCGA LGG -0.141; TCGA LIHC -0.105; TCGA OV -0.125; TCGA PRAD -0.191; TCGA THCA -0.226; TCGA STAD -0.215; TCGA UCEC -0.147 |
hsa-miR-30b-3p | GAS7 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.717; TCGA BRCA -0.16; TCGA CESC -0.255; TCGA COAD -0.389; TCGA ESCA -0.443; TCGA HNSC -0.211; TCGA KIRC -0.202; TCGA KIRP -0.138; TCGA LIHC -0.24; TCGA PAAD -0.232; TCGA PRAD -0.361; TCGA THCA -0.53; TCGA STAD -0.418; TCGA UCEC -0.159 |
hsa-miR-30b-3p | TSPAN9 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; OV; PAAD; PRAD; STAD | mirMAP | TCGA BLCA -0.156; TCGA BRCA -0.158; TCGA CESC -0.12; TCGA COAD -0.12; TCGA ESCA -0.282; TCGA HNSC -0.095; TCGA OV -0.094; TCGA PAAD -0.164; TCGA PRAD -0.057; TCGA STAD -0.145 |
hsa-miR-30b-3p | TNFRSF1B | 11 cancers: BLCA; BRCA; CESC; KIRC; KIRP; LGG; LIHC; PAAD; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.297; TCGA BRCA -0.18; TCGA CESC -0.13; TCGA KIRC -0.471; TCGA KIRP -0.117; TCGA LGG -0.117; TCGA LIHC -0.141; TCGA PAAD -0.167; TCGA PRAD -0.235; TCGA THCA -0.266; TCGA UCEC -0.203 |
hsa-miR-30b-3p | NGFR | 9 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LUSC; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.51; TCGA BRCA -0.306; TCGA COAD -0.708; TCGA ESCA -0.631; TCGA KIRC -0.448; TCGA LUSC -0.366; TCGA PRAD -0.437; TCGA STAD -0.896; TCGA UCEC -0.281 |
hsa-miR-30b-3p | VASH1 | 10 cancers: BLCA; BRCA; CESC; COAD; KIRC; KIRP; LGG; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.178; TCGA BRCA -0.138; TCGA CESC -0.156; TCGA COAD -0.209; TCGA KIRC -0.567; TCGA KIRP -0.12; TCGA LGG -0.077; TCGA PRAD -0.062; TCGA THCA -0.106; TCGA UCEC -0.149 |
hsa-miR-30b-3p | EVC | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.461; TCGA BRCA -0.126; TCGA COAD -0.499; TCGA ESCA -0.598; TCGA HNSC -0.159; TCGA PAAD -0.349; TCGA PRAD -0.101; TCGA STAD -0.422; TCGA UCEC -0.109 |
hsa-miR-30b-3p | IL2RB | 10 cancers: BLCA; BRCA; ESCA; KIRC; KIRP; LGG; LIHC; LUSC; PRAD; THCA | mirMAP | TCGA BLCA -0.48; TCGA BRCA -0.121; TCGA ESCA -0.251; TCGA KIRC -0.872; TCGA KIRP -0.307; TCGA LGG -0.293; TCGA LIHC -0.19; TCGA LUSC -0.199; TCGA PRAD -0.345; TCGA THCA -0.497 |
hsa-miR-30b-3p | NCS1 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.292; TCGA BRCA -0.07; TCGA COAD -0.209; TCGA ESCA -0.419; TCGA HNSC -0.108; TCGA LUAD -0.142; TCGA LUSC -0.148; TCGA PRAD -0.295; TCGA SARC -0.246; TCGA STAD -0.424; TCGA UCEC -0.219 |
hsa-miR-30b-3p | SH3PXD2A | 13 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LIHC; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.191; TCGA BRCA -0.076; TCGA ESCA -0.135; TCGA HNSC -0.114; TCGA KIRC -0.263; TCGA KIRP -0.124; TCGA LIHC -0.094; TCGA LUSC -0.101; TCGA PAAD -0.169; TCGA PRAD -0.341; TCGA THCA -0.135; TCGA STAD -0.124; TCGA UCEC -0.129 |
hsa-miR-30b-3p | TSPAN11 | 10 cancers: BLCA; BRCA; COAD; ESCA; LGG; LUSC; OV; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.257; TCGA BRCA -0.131; TCGA COAD -0.338; TCGA ESCA -0.195; TCGA LGG -0.153; TCGA LUSC -0.195; TCGA OV -0.208; TCGA PRAD -0.482; TCGA THCA -0.574; TCGA STAD -0.217 |
hsa-miR-30b-3p | MDGA1 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.52; TCGA BRCA -0.083; TCGA COAD -0.331; TCGA ESCA -0.299; TCGA HNSC -0.178; TCGA KIRP -0.174; TCGA PAAD -0.162; TCGA PRAD -0.224; TCGA THCA -0.278; TCGA STAD -0.37; TCGA UCEC -0.194 |
hsa-miR-30b-3p | CD93 | 9 cancers: BLCA; BRCA; CESC; COAD; KIRC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.257; TCGA BRCA -0.101; TCGA CESC -0.124; TCGA COAD -0.336; TCGA KIRC -0.273; TCGA PAAD -0.193; TCGA PRAD -0.239; TCGA STAD -0.123; TCGA UCEC -0.302 |
hsa-miR-30b-3p | WDFY4 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LIHC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.701; TCGA BRCA -0.176; TCGA CESC -0.237; TCGA COAD -0.245; TCGA ESCA -0.345; TCGA KIRC -0.607; TCGA LIHC -0.298; TCGA PAAD -0.367; TCGA PRAD -0.325; TCGA THCA -0.503; TCGA STAD -0.232; TCGA UCEC -0.179 |
hsa-miR-30b-3p | LIMD2 | 12 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; THCA | mirMAP | TCGA BLCA -0.115; TCGA BRCA -0.288; TCGA COAD -0.226; TCGA KIRC -0.611; TCGA KIRP -0.294; TCGA LGG -0.087; TCGA LIHC -0.244; TCGA LUAD -0.098; TCGA LUSC -0.131; TCGA OV -0.135; TCGA PAAD -0.186; TCGA THCA -0.571 |
hsa-miR-30b-3p | ST8SIA2 | 11 cancers: BLCA; BRCA; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; STAD | mirMAP | TCGA BLCA -0.257; TCGA BRCA -0.174; TCGA ESCA -0.795; TCGA HNSC -0.416; TCGA LGG -0.295; TCGA LUAD -0.276; TCGA LUSC -0.632; TCGA OV -0.252; TCGA PAAD -0.594; TCGA PRAD -0.253; TCGA STAD -0.6 |
hsa-miR-30b-3p | SECTM1 | 12 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LGG; LIHC; LUAD; PAAD; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.59; TCGA BRCA -0.118; TCGA COAD -0.241; TCGA KIRC -0.306; TCGA KIRP -0.18; TCGA LGG -0.187; TCGA LIHC -0.204; TCGA LUAD -0.096; TCGA PAAD -0.259; TCGA PRAD -0.254; TCGA SARC -0.177; TCGA THCA -0.564 |
hsa-miR-30b-3p | SCN2B | 9 cancers: BLCA; BRCA; COAD; ESCA; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.647; TCGA BRCA -0.269; TCGA COAD -0.689; TCGA ESCA -0.587; TCGA PAAD -0.443; TCGA PRAD -0.672; TCGA THCA -0.25; TCGA STAD -0.918; TCGA UCEC -0.573 |
hsa-miR-30b-3p | MARVELD1 | 10 cancers: BLCA; ESCA; HNSC; KIRC; KIRP; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.322; TCGA ESCA -0.215; TCGA HNSC -0.244; TCGA KIRC -0.345; TCGA KIRP -0.172; TCGA PAAD -0.242; TCGA PRAD -0.439; TCGA THCA -0.265; TCGA STAD -0.292; TCGA UCEC -0.193 |
hsa-miR-30b-3p | FMNL3 | 9 cancers: BLCA; BRCA; ESCA; KIRC; KIRP; LIHC; PAAD; PRAD; STAD | mirMAP | TCGA BLCA -0.179; TCGA BRCA -0.088; TCGA ESCA -0.181; TCGA KIRC -0.328; TCGA KIRP -0.13; TCGA LIHC -0.15; TCGA PAAD -0.154; TCGA PRAD -0.19; TCGA STAD -0.116 |
hsa-miR-30b-3p | SDC3 | 9 cancers: BLCA; HNSC; KIRC; KIRP; LGG; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.179; TCGA HNSC -0.141; TCGA KIRC -0.325; TCGA KIRP -0.223; TCGA LGG -0.123; TCGA PRAD -0.227; TCGA SARC -0.167; TCGA THCA -0.158; TCGA STAD -0.179 |
hsa-miR-30b-3p | SAMD14 | 11 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; PAAD; PRAD; SARC; THCA; UCEC | mirMAP | TCGA BLCA -0.263; TCGA BRCA -0.289; TCGA CESC -0.197; TCGA COAD -0.207; TCGA HNSC -0.132; TCGA KIRC -0.423; TCGA PAAD -0.185; TCGA PRAD -0.461; TCGA SARC -0.19; TCGA THCA -0.148; TCGA UCEC -0.169 |
hsa-miR-30b-3p | XIRP1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.929; TCGA BRCA -0.182; TCGA CESC -0.346; TCGA COAD -0.458; TCGA ESCA -0.52; TCGA KIRC -0.507; TCGA LUAD -0.45; TCGA LUSC -0.44; TCGA PAAD -0.319; TCGA PRAD -0.413; TCGA THCA -0.303; TCGA UCEC -0.166 |
hsa-miR-30b-3p | SYT12 | 10 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; THCA | mirMAP | TCGA BLCA -0.33; TCGA BRCA -0.109; TCGA COAD -0.355; TCGA HNSC -0.221; TCGA KIRC -0.696; TCGA KIRP -0.492; TCGA LUAD -0.345; TCGA LUSC -0.573; TCGA PRAD -0.186; TCGA THCA -0.546 |
hsa-miR-30b-3p | CD300LB | 9 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LIHC; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.587; TCGA BRCA -0.186; TCGA COAD -0.355; TCGA ESCA -0.227; TCGA KIRC -0.649; TCGA LIHC -0.266; TCGA PRAD -0.142; TCGA THCA -0.34; TCGA UCEC -0.244 |
hsa-miR-30b-3p | BGN | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.502; TCGA BRCA -0.305; TCGA CESC -0.188; TCGA COAD -0.512; TCGA ESCA -0.529; TCGA HNSC -0.402; TCGA KIRC -0.34; TCGA KIRP -0.294; TCGA LUAD -0.093; TCGA LUSC -0.21; TCGA PAAD -0.376; TCGA SARC -0.418; TCGA THCA -0.363; TCGA STAD -0.253; TCGA UCEC -0.263 |
hsa-miR-30b-3p | PDCD1 | 12 cancers: BLCA; BRCA; CESC; COAD; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; THCA | mirMAP | TCGA BLCA -0.696; TCGA BRCA -0.384; TCGA CESC -0.259; TCGA COAD -0.247; TCGA KIRC -0.937; TCGA KIRP -0.339; TCGA LGG -0.291; TCGA LIHC -0.447; TCGA LUAD -0.17; TCGA LUSC -0.308; TCGA PRAD -0.226; TCGA THCA -0.651 |
hsa-miR-30b-3p | NTNG2 | 12 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; THCA; STAD | mirMAP | TCGA BLCA -0.532; TCGA BRCA -0.291; TCGA COAD -0.409; TCGA ESCA -0.407; TCGA KIRC -0.457; TCGA KIRP -0.29; TCGA LIHC -0.269; TCGA LUAD -0.182; TCGA LUSC -0.178; TCGA PAAD -0.203; TCGA THCA -0.542; TCGA STAD -0.202 |
hsa-miR-30b-3p | TGM2 | 11 cancers: BLCA; BRCA; CESC; COAD; KIRC; KIRP; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.698; TCGA BRCA -0.106; TCGA CESC -0.231; TCGA COAD -0.197; TCGA KIRC -0.537; TCGA KIRP -0.399; TCGA PAAD -0.321; TCGA PRAD -0.141; TCGA THCA -0.352; TCGA STAD -0.152; TCGA UCEC -0.322 |
hsa-miR-30b-3p | COL1A1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; THCA; UCEC | miRNATAP | TCGA BLCA -0.753; TCGA BRCA -0.444; TCGA CESC -0.216; TCGA COAD -0.551; TCGA ESCA -0.604; TCGA HNSC -0.563; TCGA KIRC -0.79; TCGA KIRP -0.355; TCGA LGG -0.251; TCGA LIHC -0.407; TCGA LUAD -0.364; TCGA LUSC -0.561; TCGA PAAD -0.599; TCGA THCA -0.707; TCGA UCEC -0.153 |
hsa-miR-30b-3p | PRG4 | 9 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; PAAD; THCA; STAD | miRNATAP | TCGA BLCA -0.36; TCGA BRCA -0.199; TCGA COAD -0.445; TCGA ESCA -0.36; TCGA KIRC -0.39; TCGA KIRP -0.285; TCGA PAAD -0.277; TCGA THCA -0.659; TCGA STAD -0.244 |
hsa-miR-30b-3p | HOXC10 | 10 cancers: BLCA; BRCA; COAD; HNSC; LGG; LIHC; LUAD; LUSC; PRAD; SARC | miRNATAP | TCGA BLCA -0.55; TCGA BRCA -0.217; TCGA COAD -0.499; TCGA HNSC -0.548; TCGA LGG -0.438; TCGA LIHC -0.557; TCGA LUAD -0.422; TCGA LUSC -0.725; TCGA PRAD -0.207; TCGA SARC -0.446 |
hsa-miR-30b-3p | SLC12A4 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.12; TCGA BRCA -0.093; TCGA COAD -0.218; TCGA ESCA -0.228; TCGA HNSC -0.195; TCGA KIRC -0.151; TCGA PAAD -0.179; TCGA PRAD -0.346; TCGA SARC -0.081; TCGA STAD -0.189; TCGA UCEC -0.112 |
hsa-miR-30b-3p | VAMP1 | 9 cancers: BLCA; BRCA; KIRC; KIRP; LIHC; LUSC; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.104; TCGA BRCA -0.129; TCGA KIRC -0.279; TCGA KIRP -0.205; TCGA LIHC -0.168; TCGA LUSC -0.131; TCGA PRAD -0.081; TCGA SARC -0.215; TCGA STAD -0.105 |
hsa-miR-30b-3p | FAM65A | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.109; TCGA BRCA -0.065; TCGA COAD -0.105; TCGA ESCA -0.122; TCGA HNSC -0.093; TCGA PAAD -0.075; TCGA PRAD -0.061; TCGA STAD -0.086; TCGA UCEC -0.081 |
hsa-miR-30b-3p | BMP1 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; THCA | miRNATAP | TCGA BLCA -0.325; TCGA BRCA -0.243; TCGA COAD -0.205; TCGA ESCA -0.257; TCGA HNSC -0.265; TCGA KIRC -0.532; TCGA KIRP -0.326; TCGA LGG -0.092; TCGA LUAD -0.214; TCGA LUSC -0.184; TCGA PAAD -0.281; TCGA PRAD -0.183; TCGA THCA -0.106 |
hsa-miR-30b-3p | MYO1F | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LIHC; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.534; TCGA BRCA -0.238; TCGA CESC -0.234; TCGA COAD -0.24; TCGA ESCA -0.26; TCGA KIRC -0.81; TCGA KIRP -0.171; TCGA LGG -0.169; TCGA LIHC -0.118; TCGA PAAD -0.206; TCGA PRAD -0.209; TCGA THCA -0.4; TCGA STAD -0.113; TCGA UCEC -0.121 |
hsa-miR-30b-3p | AMPH | 9 cancers: BLCA; BRCA; COAD; ESCA; LUAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.375; TCGA BRCA -0.159; TCGA COAD -0.568; TCGA ESCA -0.368; TCGA LUAD -0.174; TCGA PRAD -0.468; TCGA THCA -0.457; TCGA STAD -0.358; TCGA UCEC -0.285 |
hsa-miR-30b-3p | PIM2 | 9 cancers: BLCA; BRCA; KIRC; KIRP; LIHC; LUAD; LUSC; SARC; THCA | miRNATAP | TCGA BLCA -0.217; TCGA BRCA -0.08; TCGA KIRC -0.346; TCGA KIRP -0.199; TCGA LIHC -0.231; TCGA LUAD -0.11; TCGA LUSC -0.189; TCGA SARC -0.173; TCGA THCA -0.475 |
hsa-miR-30b-3p | MASP1 | 10 cancers: BRCA; COAD; KIRC; LGG; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.191; TCGA COAD -1.031; TCGA KIRC -0.316; TCGA LGG -0.28; TCGA OV -0.375; TCGA PRAD -0.793; TCGA SARC -0.629; TCGA THCA -0.371; TCGA STAD -0.377; TCGA UCEC -0.844 |
hsa-miR-30b-3p | SPATS2L | 10 cancers: BRCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | MirTarget | TCGA BRCA -0.123; TCGA HNSC -0.083; TCGA KIRC -0.183; TCGA KIRP -0.096; TCGA LUAD -0.123; TCGA LUSC -0.109; TCGA PAAD -0.204; TCGA PRAD -0.171; TCGA THCA -0.128; TCGA UCEC -0.12 |
hsa-miR-30b-3p | CDCP1 | 10 cancers: BRCA; CESC; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; THCA | MirTarget | TCGA BRCA -0.11; TCGA CESC -0.116; TCGA HNSC -0.213; TCGA KIRP -0.543; TCGA LGG -0.207; TCGA LIHC -0.389; TCGA LUAD -0.254; TCGA LUSC -0.19; TCGA PRAD -0.157; TCGA THCA -0.135 |
hsa-miR-30b-3p | AGAP2 | 9 cancers: BRCA; CESC; COAD; KIRC; KIRP; LIHC; PRAD; THCA; UCEC | MirTarget | TCGA BRCA -0.159; TCGA CESC -0.181; TCGA COAD -0.235; TCGA KIRC -0.812; TCGA KIRP -0.296; TCGA LIHC -0.15; TCGA PRAD -0.105; TCGA THCA -0.265; TCGA UCEC -0.159 |
hsa-miR-30b-3p | SP140L | 10 cancers: BRCA; HNSC; KIRC; KIRP; LGG; LUAD; PAAD; PRAD; SARC; THCA | MirTarget | TCGA BRCA -0.087; TCGA HNSC -0.152; TCGA KIRC -0.242; TCGA KIRP -0.213; TCGA LGG -0.171; TCGA LUAD -0.109; TCGA PAAD -0.133; TCGA PRAD -0.363; TCGA SARC -0.216; TCGA THCA -0.279 |
hsa-miR-30b-3p | CLDN11 | 11 cancers: BRCA; CESC; COAD; KIRP; LIHC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.173; TCGA CESC -0.274; TCGA COAD -0.34; TCGA KIRP -0.282; TCGA LIHC -0.259; TCGA OV -0.168; TCGA PAAD -0.419; TCGA PRAD -0.527; TCGA THCA -0.386; TCGA STAD -0.452; TCGA UCEC -0.211 |
hsa-miR-30b-3p | PLEKHG5 | 9 cancers: BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LIHC; LUSC; PRAD | MirTarget | TCGA BRCA -0.146; TCGA CESC -0.132; TCGA ESCA -0.21; TCGA HNSC -0.197; TCGA KIRC -0.288; TCGA KIRP -0.141; TCGA LIHC -0.166; TCGA LUSC -0.126; TCGA PRAD -0.27 |
hsa-miR-30b-3p | APOBEC3F | 9 cancers: BRCA; KIRC; KIRP; LGG; LIHC; LUSC; PRAD; THCA; STAD | MirTarget | TCGA BRCA -0.095; TCGA KIRC -0.362; TCGA KIRP -0.171; TCGA LGG -0.15; TCGA LIHC -0.143; TCGA LUSC -0.09; TCGA PRAD -0.388; TCGA THCA -0.175; TCGA STAD -0.222 |
hsa-miR-30b-3p | ZNF385A | 10 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; PAAD | MirTarget; miRNATAP | TCGA BRCA -0.203; TCGA CESC -0.167; TCGA COAD -0.268; TCGA ESCA -0.432; TCGA HNSC -0.153; TCGA KIRC -0.214; TCGA KIRP -0.166; TCGA LIHC -0.239; TCGA LUAD -0.081; TCGA PAAD -0.129 |
hsa-miR-30b-3p | UNC5B | 9 cancers: BRCA; COAD; ESCA; HNSC; KIRC; LIHC; LUSC; PAAD; PRAD | MirTarget | TCGA BRCA -0.153; TCGA COAD -0.158; TCGA ESCA -0.232; TCGA HNSC -0.164; TCGA KIRC -0.423; TCGA LIHC -0.142; TCGA LUSC -0.143; TCGA PAAD -0.155; TCGA PRAD -0.419 |
hsa-miR-30b-3p | CDH23 | 9 cancers: BRCA; COAD; ESCA; KIRC; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.139; TCGA COAD -0.29; TCGA ESCA -0.439; TCGA KIRC -0.552; TCGA PRAD -0.52; TCGA SARC -0.283; TCGA THCA -0.268; TCGA STAD -0.356; TCGA UCEC -0.285 |
hsa-miR-30b-3p | SPOCD1 | 15 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | mirMAP | TCGA BRCA -0.255; TCGA CESC -0.323; TCGA COAD -0.396; TCGA ESCA -0.46; TCGA HNSC -0.669; TCGA KIRC -0.612; TCGA KIRP -0.455; TCGA LIHC -0.542; TCGA LUAD -0.365; TCGA LUSC -0.152; TCGA PAAD -0.451; TCGA PRAD -0.234; TCGA SARC -0.788; TCGA THCA -0.486; TCGA UCEC -0.168 |
hsa-miR-30b-3p | TTYH3 | 10 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; THCA | mirMAP | TCGA BRCA -0.193; TCGA CESC -0.124; TCGA HNSC -0.243; TCGA KIRC -0.554; TCGA KIRP -0.14; TCGA LIHC -0.121; TCGA LUAD -0.11; TCGA LUSC -0.185; TCGA PAAD -0.162; TCGA THCA -0.166 |
hsa-miR-30b-3p | HOXA1 | 10 cancers: BRCA; CESC; HNSC; KIRP; LGG; LUAD; LUSC; OV; PAAD; UCEC | miRNATAP | TCGA BRCA -0.095; TCGA CESC -0.206; TCGA HNSC -0.358; TCGA KIRP -0.164; TCGA LGG -0.571; TCGA LUAD -0.334; TCGA LUSC -0.209; TCGA OV -0.399; TCGA PAAD -0.284; TCGA UCEC -0.271 |
hsa-miR-30b-3p | VASH2 | 11 cancers: COAD; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD | MirTarget | TCGA COAD -0.179; TCGA KIRC -0.144; TCGA KIRP -0.138; TCGA LGG -0.222; TCGA LUAD -0.118; TCGA LUSC -0.143; TCGA OV -0.197; TCGA PAAD -0.303; TCGA PRAD -0.118; TCGA THCA -0.29; TCGA STAD -0.168 |
hsa-miR-30b-3p | TMEM47 | 9 cancers: COAD; ESCA; KIRP; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA COAD -0.432; TCGA ESCA -0.37; TCGA KIRP -0.117; TCGA OV -0.182; TCGA PAAD -0.153; TCGA PRAD -0.343; TCGA SARC -0.536; TCGA STAD -0.561; TCGA UCEC -0.379 |
hsa-miR-30b-3p | RIT1 | 10 cancers: COAD; HNSC; KIRC; KIRP; LGG; LIHC; OV; PAAD; PRAD; STAD | MirTarget | TCGA COAD -0.074; TCGA HNSC -0.105; TCGA KIRC -0.248; TCGA KIRP -0.052; TCGA LGG -0.086; TCGA LIHC -0.106; TCGA OV -0.178; TCGA PAAD -0.07; TCGA PRAD -0.051; TCGA STAD -0.079 |
hsa-miR-30b-3p | FAM102B | 10 cancers: KIRC; KIRP; LIHC; LUAD; OV; PAAD; PRAD; SARC; THCA; UCEC | MirTarget | TCGA KIRC -0.288; TCGA KIRP -0.157; TCGA LIHC -0.19; TCGA LUAD -0.074; TCGA OV -0.111; TCGA PAAD -0.124; TCGA PRAD -0.111; TCGA SARC -0.19; TCGA THCA -0.169; TCGA UCEC -0.13 |
Enriched cancer pathways of putative targets